Inflammatory Biomarkers in Patients with Asymptomatic Primary Hyperparathyroidism

被引:19
作者
Emam, Ahmed Alsayed [1 ]
Mousa, Sabela Gomaa
Ahmed, Karema Yousif
Al-Azab, Adel A. [2 ]
机构
[1] Al Azhar Univ, Dept Internal Med, Natl Res Ctr, Cairo, Egypt
[2] Ain Shams Univ, Cairo, Egypt
关键词
Asymptomatic primary hyperparathyroidism; Highly sensitive C-reactive protein; Interleukin-6; C-REACTIVE PROTEIN; HORMONE-RELATED PROTEIN; NECROSIS-FACTOR-ALPHA; CIRCULATING LEVELS; BONE-RESORPTION; INTERLEUKIN-6; MARKERS; PEPTIDE; RISK;
D O I
10.1159/000334588
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To assess highly sensitive C-reactive protein (hs-CRP) and interleukin-6 (IL-6) as inflammatory biomarkers in patients with asymptomatic primary hyperparathyroidism (PHPT). Materials and Methods: A total of 26 patients with asymptomatic PHPT and 22 age- and sex-matched individuals as a control group were recruited for the study. Corrected serum calcium, phosphorus, alkaline phosphatase, serum 25-hydroxyvitamin D, intact parathyroid hormone (PTH), hs-CRP and IL-6 were measured for all subjects. Results: Serum hs-CRP and IL-6 were significantly higher in asymptomatic PHPT patients than in the control group (hs-CRP: 4.15 +/- 0.54 vs. 2.24 +/- 0.11 mg/l; IL-6: 4.50 +/- 0.80 vs. 2.56 +/- 0.29 pg/ml; p < 0.001). Moreover, in asymptomatic PHPT patients, serum PTH was significantly correlated with hs-CRP and IL-6 (r = 0.820, p < 0.001 and r = 0.787, p < 0.001, respectively). Conclusion: Inflammatory biomarkers were higher in patients with asymptomatic PHPT than in controls. Moreover, serum PTH was significantly correlated with inflammatory biomarkers which may suggest a subclinical inflammatory response in this group of patients. Copyright (C) 2011 S. Karger AG, Basel
引用
收藏
页码:249 / 253
页数:5
相关论文
共 29 条
  • [11] A role for interleukin-6 in parathyroid hormone-induced bone resorption in vivo
    Grey, A
    Mitnick, MA
    Masiukiewicz, U
    Sun, BH
    Rudikoff, S
    Jilka, RL
    Manolagas, SC
    Insogna, K
    [J]. ENDOCRINOLOGY, 1999, 140 (10) : 4683 - 4690
  • [12] Hedbäck G, 1998, EUR J CLIN INVEST, V28, P271
  • [13] INTERLEUKIN-6 AND THE ACUTE PHASE RESPONSE
    HEINRICH, PC
    CASTELL, JV
    ANDUS, T
    [J]. BIOCHEMICAL JOURNAL, 1990, 265 (03) : 621 - 636
  • [14] Hutchinson WL, 2000, CLIN CHEM, V46, P934
  • [15] Kiernan Thomas J, 2006, Int J Cardiol, V113, pE89, DOI 10.1016/j.ijcard.2006.05.033
  • [16] Biomarkers of atherosclerotic plaque instability and rupture
    Koenig, Wolfgang
    Khuseyinova, Natalie
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (01) : 15 - 26
  • [17] Cardiovascular risk factors in primary hyperparathyroidism
    Luboshitzky, R.
    Chertok-Schaham, Y.
    Lavi, I.
    Ishay, A.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (04) : 317 - 321
  • [18] Parathyroid hormone induces hepatic production of bioactive interleukin-6 and its soluble receptor
    Mitnick, MA
    Grey, A
    Masiukiewicz, U
    Bartkiewicz, M
    Rios-Velez, L
    Friedman, S
    Xu, LM
    Horowitz, MC
    Insogna, K
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2001, 280 (03): : E405 - E412
  • [19] Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI [10.1016/j.echo.2008.11.023, 10.1093/ejechocard/jep007]
  • [20] Circulating levels of interleukin-6 soluble receptor predict rates of bone loss in patients with primary hyperparathyroidism
    Nakchbandi, IA
    Mitnick, MA
    Lang, R
    Gundberg, C
    Kinder, B
    Insogna, K
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11) : 4946 - 4951